Sodium valproate and valproic acid seem to lower barbiturate metabolism; hence, barbiturate blood stages must be monitored and acceptable dosage changes manufactured as indicated. pentobarbital will minimize the extent or impact of gefitinib by influencing hepatic/intestinal enzyme CYP3A4 metabol